family history of atopy and they do recommend allergy evaluation via testing; these were similar between all groups.When comparisons were made between the groups, these areas showed statistically significant differences: 1) Practitioners who see more patients with EoE more frequently were more likely to perform testing for immediate hypersensitivities to aeroallergens and foods. 2) Practitioners who participate more often in workshops were less likely to perfrom patch testing for foods. Conclusions: Our survey reveals that allergy practitioners worldwide are following patients with EoE. Practitioners who see more patients with EoE more frequently are more likely to perform allergy testing in form of hypersensitivity testing to both aeroallergens and foods. This could be secondary to participation in educational sessions or more interest in searching the literature. Participation in workshops has an inverse relation to performing patch testing for foods, which may show that current education does not support this practice. In order to have a more uniform approach to patients with EoE, a consensus guideline is prudential.
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Allergen Specific Immunotherapy as a Treatment for Eosinophilic Esophagitis
Juan Esteban Perez, Thanai Pongdee, MD, and Juan Guarderas, MD. Allergy and Pulmonary Medicine, Mayo Clinic, Jacksonville, FL. Background: Eosinophilic Esophagitis (EoE) is an inflammatory disease that reduces the ability of the esophagus to pass food, often leading to dysphagia. A relationship between EoE and food allergies has been determined. However, there have been several documented cases in which patients had negative prick skin testing (PST) results for food allergens and positive results for airborne environmental allergens, and still have a confirmed diagnosis of EoE. Recently, airborne allergens have been implicated in the onset of this condition. Studies have shown that patients sensitive to airborne allergens such as pollen have a seasonal biannual component in which the severity of EoE symptoms increase, coinciding with high pollen seasons. Methods: We followed a 65-year-old man with a history of allergies complaining of an increase in his symptoms of allergic rhinitis and asthma. He also noted dysphagia and occasional vomiting. We noted the disease and medication course over 5 years of treatment. Results: The patient underwent an esophagogastroduodenoscopy with biopsy, in which midesophageal rings as well as an 8 mm sessile polyp were found, suggesting EoE. Histological analysis confirmed EoE, having found .20 intraepithelial eosinophils/HPF. The patient was treated with a short term prednisone regimen, as well as maintenance medications consisting of inhaled corticosteroids and antihistamines. The patient returned 6 months after the initial consultation and still presented symptoms of EoE, at which point the patient was prescribed proton pump inhibitors. In addition, allergen specific immunotherapy was initiated for confirmed airborne allergens. The patient was examined after 5 years of immunotherapy treatment. Not only did he report that his allergic rhinitis and asthma symptoms were controlled, but his EoE symptoms had resolved. Conclusions: Results suggest that immunotherapy for airborne allergens could be a successful treatment for EoE. A larger study is needed to determine if allergen specific immunotherapy is a viable treatment option for EoE in similar cases. Such a study could include patients with EoE and confirmed airborne allergies treated with immunotherapy while monitoring a number of eosinophilic and lymphocytic markers. Background: The Allergies surveys have been conducted in several regions of the world, and provide a uniquely comprehensive insight into the prevalence and impact of nasal allergies worldwide. Here we report specifically on treatment of nasal allergies in the Allergies in America (AIA), Asia Pacific (AIAP), Latin America (AILA) and Middle East (AIME) surveys. Methods: Patients who were previously diagnosed by a health care professional with nasal allergies (hay fever, allergic rhinitis or nasal allergies, plus sinus disease in AIAP), exhibited symptoms, and/or had received treatment, were included. Standardized questionnaires provided by Abt SRBI were used; individual questions and methodology varied slightly between regions. In total, around 90,000 households were screened, including responses from 6,081 patients. Results: The surveys revealed that among patients receiving treatment for nasal allergies, the proportion using a prescription nasal spray varied regionally, from 21% in AIAP to 54% in AIME. Despite a high percentage of patients reporting satisfaction with their prescription nasal spray, many patients who were dissatisfied cited reasons such as lack of effectiveness and lack of 24-hour relief as primary concerns. The percentage of allergy sufferers who experienced a loss of product effectiveness over 24 hours varied regionally from 35% in AILA to 53% in AIAP. Many patients strongly agreed there were no truly effective treatments for nasal allergies, and 10% of all patients in AIA chose to change their medication several times a year. The most commonly reported side effects of prescription medications were dripping down the throat and dryness. Bad taste was also commonly reported, in all regions except North America, where drowsiness was the third most commonly reported side effect. A higher proportion of patients reported side effects with prescription sprays in the Middle East than in any other region surveyed. Conclusions: There is still an unmet need in treatment of patients with nasal allergies worldwide. A low percentage receives treatment with prescription nasal sprays, despite this form of therapy being considered the 'gold standard' of treatments. Patients are bothered by a range of side effects generally different to those reported in drug information leaflets. (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) were analyzed to compare the likelihood of receiving targeted comorbid allergyrelated respiratory conditions among AR-diagnosed (ICD-9 477.x) children (age ,18 years) and adults (age $18 years). Targeted comorbidities included strep throat (ICD-9 034.x), conjunctivitis (372.x), otitis media (381.x-382.x), acute respiratory infections (460.x-466.x), other diseases of the upper respiratory tract (470.x-476.x and 478.x), pneumonia/influenza (480.x-488.x), chronic obstructive pulmonary disease/allied conditions (490-496), asthma (ICD-9 493.x), and atopic dermatitis (691.8).
EPIDEMIOLOGY OF ALLERGIC RHINITIS
Results: Overall rates of AR were significantly higher for children than adults (8% vs 3%, P , 0.0001). On average, AR-diagnosed patients had significantly more comorbid allergy-related respiratory conditions than nonARdiagnosed patients (children, 3.7 6 1.9 vs 1.2 6 1.7 P , 0.0001; adults, 2.6 6 1.7 vs 0.5 6 1.0, P , 0.0001). Compared to nonAR-diagnosed 
